Genistein suppresses NF-κB activation, reduces TNF-α and IL-6 production, and reactivates insulin-mediated Akt and endothelial NO synthase phosphorylation to improve insulin resistance-related endothelial dysfunction. The gene discussed is IL6; the disease is Insulin resistance.